DK183583A - Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner - Google Patents

Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner Download PDF

Info

Publication number
DK183583A
DK183583A DK183583A DK183583A DK183583A DK 183583 A DK183583 A DK 183583A DK 183583 A DK183583 A DK 183583A DK 183583 A DK183583 A DK 183583A DK 183583 A DK183583 A DK 183583A
Authority
DK
Denmark
Prior art keywords
benzoazacycloalkyl
imidazolidines
spiro
preparing
procedure
Prior art date
Application number
DK183583A
Other languages
Danish (da)
English (en)
Other versions
DK183583D0 (da
Inventor
Charles Malen
Jean-Louis Peglion
Jacques Duhault
Michelle Boulanger
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of DK183583D0 publication Critical patent/DK183583D0/da
Publication of DK183583A publication Critical patent/DK183583A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK183583A 1982-04-27 1983-04-26 Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner DK183583A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8207203 1982-04-27
FR8207203A FR2525603A1 (fr) 1982-04-27 1982-04-27 Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
DK183583D0 DK183583D0 (da) 1983-04-26
DK183583A true DK183583A (da) 1983-10-28

Family

ID=9273425

Family Applications (1)

Application Number Title Priority Date Filing Date
DK183583A DK183583A (da) 1982-04-27 1983-04-26 Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner

Country Status (22)

Country Link
JP (1) JPS5910584A (enExample)
KR (1) KR840004428A (enExample)
AT (1) ATA125383A (enExample)
AU (1) AU1395383A (enExample)
BE (1) BE896572A (enExample)
DD (1) DD209833A5 (enExample)
DE (1) DE3315106A1 (enExample)
DK (1) DK183583A (enExample)
ES (1) ES8405796A1 (enExample)
FR (1) FR2525603A1 (enExample)
GB (1) GB2133401B (enExample)
GR (1) GR78481B (enExample)
IL (1) IL68497A0 (enExample)
IT (1) IT1167123B (enExample)
LU (1) LU84770A1 (enExample)
MA (1) MA19783A1 (enExample)
NL (1) NL8301476A (enExample)
NO (1) NO831473L (enExample)
OA (1) OA07412A (enExample)
PT (1) PT76595B (enExample)
SE (1) SE8302347L (enExample)
ZA (1) ZA832927B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
EA016558B1 (ru) 2003-06-17 2012-05-30 Арена Фармасьютикалз, Инк. Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором
SI2332921T1 (sl) 2003-06-17 2016-06-30 Arena Pharmaceuticals, Inc. 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid
WO2006069363A2 (en) 2004-12-21 2006-06-29 Arena Pharmaceuticals, Inc. Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
RS50997B (sr) 2004-12-23 2010-10-31 Arena Pharmaceuticals Inc. Kompozicije 5ht2c receptor modulatora i postupci njihove upotrebe
EP2001852A2 (en) 2006-04-03 2008-12-17 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
ES2522587T3 (es) 2006-12-05 2014-11-17 Arena Pharmaceuticals, Inc. Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma
CN102015591B (zh) 2008-03-04 2014-01-29 艾尼纳制药公司 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
EP2443080A2 (en) 2009-06-18 2012-04-25 Arena Pharmaceuticals, Inc. Process for the preparation of 5-ht2c receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
CN103189360A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的非吸湿性盐
CN103189359A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的光学活性酸盐
ES2704455T3 (es) 2010-09-01 2019-03-18 Arena Pharm Inc Formas farmacéuticas de liberación modificada de agonistas de 5-HT2C útiles para la gestión del peso
WO2012030939A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
AU2012392187B2 (en) 2012-10-09 2018-07-12 Arena Pharmaceuticals, Inc. Method of weight management

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
IT1167123B (it) 1987-05-13
FR2525603B1 (enExample) 1984-09-14
NL8301476A (nl) 1983-11-16
DD209833A5 (de) 1984-05-23
KR840004428A (ko) 1984-10-15
JPS5910584A (ja) 1984-01-20
LU84770A1 (fr) 1984-11-28
PT76595A (fr) 1983-05-01
SE8302347D0 (sv) 1983-04-26
NO831473L (no) 1983-10-28
PT76595B (fr) 1986-01-21
IT8348155A0 (it) 1983-04-26
IL68497A0 (en) 1983-07-31
OA07412A (fr) 1984-11-30
GB2133401A (en) 1984-07-25
GB8311508D0 (en) 1983-06-02
DK183583D0 (da) 1983-04-26
MA19783A1 (fr) 1983-12-31
GR78481B (enExample) 1984-09-27
ZA832927B (en) 1984-06-27
AU1395383A (en) 1983-11-03
ATA125383A (de) 1986-05-15
SE8302347L (sv) 1983-10-28
ES521895A0 (es) 1984-06-16
ES8405796A1 (es) 1984-06-16
DE3315106A1 (de) 1983-11-03
GB2133401B (en) 1985-10-23
FR2525603A1 (fr) 1983-10-28
BE896572A (fr) 1983-10-26

Similar Documents

Publication Publication Date Title
DK183583A (da) Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner
NO942415L (no) Fremgangsmåte for fremstilling av behandling av surgass og hydrokarbonvæskeströmmer
CA2126305A1 (en) New treatments using venlafaxine
GB857576A (en) Substituted biguanides
ES410174A1 (es) Procedimiento para la preparacion de etambutol.
DE3376190D1 (de) N-azidophenylsulfonyl-n'-pyrimidinyl- and -triazinyl urea
ES446598A1 (es) Procedimiento de preparacion de compuestos piperazinicos.
SE7602838L (sv) Saltbad for stortkylning av badnitrerade konstruktionselement
JPS57156411A (en) Hair-treating agent
SE8200309L (sv) Guanidinocyklohexankarboxylsyraderivat
DK229480A (da) Fremgangsmaade til fremstilling af guanidinderivater deres tautomere forbindelser og salte
SE7606063L (sv) Forfarande for framstellning av tienopyridininderivat
BR8105438A (pt) Processo para a preparacao de ureias n-sulfeniladas,composicoes fungicidas,processos de combate a fungos e de preparacao de composicoes
JPS5321857A (en) Method of treating ammonia-containing liquid
ATE20349T1 (de) Heterocyclisch substituierte nitrile, ihre herstellung und verwendung als arzneimittel.
JPS57145950A (en) Platinum alloy for accessory
FR1233866A (fr) Procédé de préparation de mono- et polyisocyanates inoffensifs au point de vue physiologique, avec une faible pression de vapeur
JPS5430156A (en) Synthesis of benzamide derivative
IE780577L (en) Propanolamines
JPS5283533A (en) 6-substituted naphtehalene-2-oxyalkylamines
SU503934A1 (ru) Дисперсионно-твердеющий элинвар
GB1086527A (en) Urea derivatives and mixtures containing them
SU532597A1 (ru) Способ кондиционировани сложных удобрений
TH3418A (th) เบนโซอิลเฟนนิลยูเรีย
ES8100295A3 (es) Procedimiento para preparar xantinas sustituidas

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment